*Corresponding author:Alisina Shahi MD, Clinical Research Department, Rothman Institute at Thomas Jefferson University, Sheridan Building, Suite 1000, 125 South 9th Street, Philadelphia, PA 19107, USA
Received: October 14, 2017; Published: October 20, 2017
To view the Full Article Peer-reviewed Article PDF
Periprosthetic joint infection (PJI) is one of the most dreaded complications after total joint arthroplasty . There is no gold standard for diagnosing PJI, hence, a clinician who encounters a suspected PJI case, ought to use a combination of tests. All of which, besides their expense can be invasive and even this can’t provide 100% accuracy . Several biomarkers have been introduced that are potentially reliable tools for diagnosing PJI . In this article, we aimed to review the current diagnostic measures of PJI with a special focus on molecular biomarkers.